DUOBODY Trademark

Trademark Overview


On Thursday, June 6, 2013, a trademark application was filed for DUOBODY with the United States Patent and Trademark Office. The USPTO has given the DUOBODY trademark a serial number of 79135579. The federal status of this trademark filing is SECTION 71 ACCEPTED as of Wednesday, February 24, 2021. This trademark is owned by Genmab A/S. The DUOBODY trademark is filed in the Chemical Products, Pharmaceutical Products, Computer & Software Services & Scientific Services, Personal, and Legal & Social Services categories with the following description:

Pharmaceutical [ and veterinary ] preparations, namely, pharmaceutical preparations based on antibodies, bi and multispecific antibodies as well as fragments, including monovalent antibodies, derivatives or conjugates of any of these for use with regard to treatment of cancer, infectious diseases, immune and autoimmune diseases, inflammatory diseases, neurodegenerative diseases and cardiovascular diseases

Legal services in the form of patent exploitation and licensing of intellectual property in the field of medicines

[ Chemical, ] biochemical, biological and biotechnological preparations, especially antibodies, and bi and multi specific antibodies as well as fragments, including monovalent antibodies, derivatives or conjugates of any of these, all for vitro and in vivo scientific and industrial research and development with regard to diseases

Medical, scientific and biological research, especially research into antibodies and bi and multispecific antibodies or fragments, including monovalent antibodies, derivatives or conjugates of any of these and development of pharmaceutical products based on antibodies and bi and multispecific antibodies or fragments, including monovalent antibodies, derivatives or conjugates of any of these; chemical analysis; computer programming, namely, programming of computers for the collection and processing of medical data in medical scientific research, development and therapy, including scientific research, development and therapy with antibodies, bi and multispecific antibodies or fragments, including monovalent antibodies, derivatives or conjugates of any of these
duobody

General Information


Serial Number79135579
Word MarkDUOBODY
Filing DateThursday, June 6, 2013
Status706 - SECTION 71 ACCEPTED
Status DateWednesday, February 24, 2021
Registration Number4582290
Registration DateTuesday, August 12, 2014
Mark Drawing3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, May 27, 2014

Trademark Statements


Description of the Colors ClaimedThe word "DuoBody" and top/right half of the circle is black, the bottom/left half of the circle is grey.
Goods and ServicesPharmaceutical [ and veterinary ] preparations, namely, pharmaceutical preparations based on antibodies, bi and multispecific antibodies as well as fragments, including monovalent antibodies, derivatives or conjugates of any of these for use with regard to treatment of cancer, infectious diseases, immune and autoimmune diseases, inflammatory diseases, neurodegenerative diseases and cardiovascular diseases
Pseudo MarkDUO BODY
Indication of Colors claimedThe color(s) black and grey is/are claimed as a feature of the mark.
Goods and ServicesLegal services in the form of patent exploitation and licensing of intellectual property in the field of medicines
Goods and Services[ Chemical, ] biochemical, biological and biotechnological preparations, especially antibodies, and bi and multi specific antibodies as well as fragments, including monovalent antibodies, derivatives or conjugates of any of these, all for vitro and in vivo scientific and industrial research and development with regard to diseases
Goods and ServicesMedical, scientific and biological research, especially research into antibodies and bi and multispecific antibodies or fragments, including monovalent antibodies, derivatives or conjugates of any of these and development of pharmaceutical products based on antibodies and bi and multispecific antibodies or fragments, including monovalent antibodies, derivatives or conjugates of any of these; chemical analysis; computer programming, namely, programming of computers for the collection and processing of medical data in medical scientific research, development and therapy, including scientific research, development and therapy with antibodies, bi and multispecific antibodies or fragments, including monovalent antibodies, derivatives or conjugates of any of these

Classification Information


International Class001 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry; unprocessed artificial resins; unprocessed plastics; manures; fire extinguishing compositions; tempering and soldering preparations; chemical substances for preserving foodstuffs; tanning substances; adhesives used in industry.
US Class Codes001, 005, 006, 010, 026, 046
Class Status Code6 - Active
Class Status DateWednesday, September 18, 2013
Primary Code001
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, September 18, 2013
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateWednesday, September 18, 2013
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class045 - Legal services; security services for the protection of property and individuals; personal and social services rendered by others to meet the needs of individuals.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateWednesday, September 18, 2013
Primary Code045
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameGenmab A/S
Party Type30 - Original Registrant
Legal Entity Type16 - Limited Liability Company
AddressDK

Party NameGenmab A/S
Party Type20 - Owner at Publication
Legal Entity Type16 - Limited Liability Company
AddressDK

Party NameGenmab A/S
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressDK

Trademark Events


Event DateEvent Description
Tuesday, September 24, 2013APPLICATION FILING RECEIPT MAILED
Friday, September 13, 2013SN ASSIGNED FOR SECT 66A APPL FROM IB
Wednesday, September 18, 2013NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, September 19, 2013ASSIGNED TO EXAMINER
Friday, September 20, 2013NON-FINAL ACTION WRITTEN
Saturday, September 21, 2013NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Monday, September 23, 2013REFUSAL PROCESSED BY MPU
Monday, September 23, 2013NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Thursday, April 24, 2014LAW OFFICE PUBLICATION REVIEW COMPLETED
Wednesday, October 16, 2013REFUSAL PROCESSED BY IB
Monday, March 24, 2014TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, March 24, 2014CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, March 24, 2014TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, April 2, 2014EXAMINERS AMENDMENT -WRITTEN
Wednesday, April 2, 2014EXAMINER'S AMENDMENT ENTERED
Wednesday, April 2, 2014EXAMINERS AMENDMENT MAILED
Thursday, April 3, 2014APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, April 24, 2014ASSIGNED TO LIE
Wednesday, November 12, 2014FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Wednesday, May 7, 2014NOTICE OF PUBLICATION
Wednesday, May 7, 2014NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Wednesday, May 7, 2014NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Friday, May 23, 2014NOTIFICATION PROCESSED BY IB
Tuesday, May 27, 2014PUBLISHED FOR OPPOSITION
Tuesday, August 12, 2014REGISTERED-PRINCIPAL REGISTER
Thursday, September 4, 2014TEAS SECTION 7 REQUEST RECEIVED
Sunday, September 14, 2014CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Monday, September 22, 2014POST REGISTRATION ACTION MAILED - SEC. 7
Friday, February 13, 2015FINAL DECISION TRANSACTION PROCESSED BY IB
Thursday, April 20, 2017NEW REPRESENTATIVE AT IB RECEIVED
Thursday, October 26, 2017CHANGE OF NAME/ADDRESS REC'D FROM IB
Wednesday, February 3, 2021TEAS SECTION 71 RECEIVED
Tuesday, January 27, 2015FINAL DISPOSITION PROCESSED
Tuesday, January 27, 2015FINAL DISPOSITION NOTICE SENT TO IB
Wednesday, July 27, 2016REGISTERED - SEC. 7 REQUEST ABANDONED
Thursday, February 9, 2017CHANGE OF NAME/ADDRESS REC'D FROM IB
Thursday, February 9, 2017NEW REPRESENTATIVE AT IB RECEIVED
Friday, September 8, 2017NEW REPRESENTATIVE AT IB RECEIVED
Wednesday, February 24, 2021REGISTERED-SEC.71 ACCEPTED
Sunday, November 14, 2021INVALIDATION PROCESSED
Tuesday, February 23, 2021CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Wednesday, February 24, 2021NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED
Sunday, October 24, 2021PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED
Friday, September 15, 2023CHANGE OF NAME/ADDRESS REC'D FROM IB
Sunday, November 14, 2021PARTIAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
Saturday, December 25, 2021PARTIAL INVALIDATION PROCESSED BY THE IB
Friday, April 7, 2023INTERNATIONAL REGISTRATION RENEWED
Saturday, August 12, 2023COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED
Wednesday, June 5, 2024TEAS CHANGE OF OWNER ADDRESS RECEIVED
Wednesday, June 5, 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, June 5, 2024ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, June 5, 2024TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Wednesday, June 5, 2024TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, June 5, 2024APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED